KRM Ayurveda IPO

Lot size and investment

Reservation

QIB

25,74,000 shares (49.83% of the Offer)

NII

7,80,000 shares (15.10% of the Offer)

Retail

18,12,000 shares (35.08% of the Offer)

Current GMP

₹19

▲+14.00%

Estimated listing price

₹154

Issue price ₹135

Highest

₹21

20 Jan

Lowest

₹0

14 Jan

GMP by day (₹ per share)

Kostak rate

₹0

Subject to sauda

₹14,400

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

P/E Ratio

23.73

EPS (₹)

5.69

RoCE

43.33%

RoNW

67.86%

PAT Margin

15.80%

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country.

Objects of the issue

1. Capital Expenditure for Construction and Development of Telemedicine Operational Facilities₹13.67 Cr
2. Purchase of CRM Software and Hardware Infrastructure₹1.42 Cr
3. Human Resources₹5.44 Cr
4. Repayment/Prepayment of loan₹12.5 Cr
5. Working Capital Requirement₹22.9 Cr
6. General Corporate Purposes₹10 Cr

Promoters and shareholding

Puneet Dhawan and Tanya Dhawan

Promoter holding, pre-issue

92.16%

Promoter holding, post-issue

67.28%